Health Condition 1: H259- Unspecified age-related cataract
Conditions
Interventions
Intervention1: Subconjunctival triamcinolone acetonide injection: Subconjunctival triamcinolone acetonide suspension 0.5 ml at a concentration of 40mg/ml injection given during cataract surgery for re
Sponsors
School of medical sciences and research
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients eligible for cataract surgery under peribulbar anesthesia. 2. Patients with uneventful cataract surgery.
Exclusion criteria
Exclusion criteria: 1. Patients with uncontrolled diabetes mellitus, or glaucoma, patients with a prior history of uveitis, and patients on systemic anti-inflammatory treatment. 2. Patients with corneal diseases, infectious ocular lesions, and high myopes. 3. Patients with existing retinal abnormalities. 4. Patients with complicated cataract surgery and prior ocular surgery. 6. Patients with documented allergy to triamcinolone acetonide. 7. Patients not responding to SCTA injection given during surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of subconjunctival triamcinolone acetonide suspension 0.5 ml at a concentration of 40mg/ml injection given during cataract surgery for reducing post-operative intra-ocular inflammation.Timepoint: Day 1, 7, 30, 90 | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of postoperative 1 % prednisolone eye drops in preventing intraocular inflammation following phacoemulsification.Timepoint: Day 1, 7, 30, 90;To compare the visual acuity, contrast sensitivity and steroid response, in cases of subconjunctival triamcinolone with the topical prednisolone eye drops in phacoemulsification. Timepoint: Day 1, 7, 30, 90 | — |
Countries
India
Contacts
Public ContactDr Abha Gahlot
school of medical sciences and research
Outcome results
None listed